Ti
A549 Cells
Apoptosis
/ drug effects
Biomarkers, Tumor
/ metabolism
Carcinoma, Non-Small-Cell Lung
/ drug therapy
Cell Line, Tumor
Cell Movement
/ drug effects
Epithelial-Mesenchymal Transition
/ drug effects
Humans
Integrins
/ metabolism
Lung
/ drug effects
Lung Neoplasms
/ drug therapy
Nanostructures
/ administration & dosage
Neoplastic Stem Cells
/ drug effects
Proto-Oncogene Proteins c-akt
/ metabolism
Receptor, Notch1
/ metabolism
Snail Family Transcription Factors
/ metabolism
Superoxides
/ metabolism
Transcription Factors
/ metabolism
Vimentin
/ metabolism
Journal
Molecular pharmacology
ISSN: 1521-0111
Titre abrégé: Mol Pharmacol
Pays: United States
ID NLM: 0035623
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
13
09
2018
accepted:
02
02
2019
pubmed:
10
2
2019
medline:
15
6
2019
entrez:
10
2
2019
Statut:
ppublish
Résumé
Recent research into the cancer stem cell (CSC) concept has driven progress in the understanding of cancer biology and has revealed promising CSC-specific targets for drug discovery efforts. As malignancies of lung cancer have been shown to be strongly associated with activities of CSCs, we examined the effects of Ti
Identifiants
pubmed: 30737252
pii: mol.118.114447
doi: 10.1124/mol.118.114447
doi:
Substances chimiques
Biomarkers, Tumor
0
Integrins
0
Receptor, Notch1
0
Snail Family Transcription Factors
0
Transcription Factors
0
Vimentin
0
Superoxides
11062-77-4
Proto-Oncogene Proteins c-akt
EC 2.7.11.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
418-432Informations de copyright
Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics.